Skip to main content
Harbin Pharmaceutical Group Co.,Ltd. logo

Harbin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600664 ISIN · CNE0000009T3 LEI · 300300G0L086UJ23MI26 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,827 across all filing types
Latest filing 2017-03-03 Annual Report
Country CN China
Listing Shanghai Stock Exchange 600664

About Harbin Pharmaceutical Group Co.,Ltd.

https://www.hayao.com/

Harbin Pharmaceutical Group Co., Ltd. specializes in the research, development, manufacture, and distribution of a diverse range of pharmaceutical and healthcare products. The company's portfolio includes antibiotics, over-the-counter (OTC) medicines, health supplements, traditional Chinese medicines, and animal health products. It operates through several specialized subsidiaries and maintains a significant presence in the production of penicillins and cephalosporins. A key strategic focus involves the health and nutrition sector, bolstered by the acquisition of global nutrition brand GNC. The company leverages large-scale manufacturing capabilities and an extensive distribution network to serve both domestic and international markets. Its operations emphasize technological innovation and quality control across its integrated supply chain, from raw material production to finished dosage forms.

Recent filings

Filing Released Lang Actions
2016年年度报告
Annual Report Classification · 100% confidence The document is titled "2016 年年度报告" which translates to "2016 Annual Report". It contains detailed financial data, company business overview, management discussion and analysis, risk disclosures, and other comprehensive information typical of a full annual report. The document length is 15,000 characters, indicating a full report rather than a brief announcement. It includes audited financial statements, auditor's opinion, profit distribution plans, and detailed sections on company operations and financial performance. These characteristics align with the definition of an Annual Report (10-K). FY 2016
2017-03-03 Chinese
关于召开2016年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a notice about the convening of the 2016 Annual General Meeting (AGM) of 哈药集团股份有限公司, including details about the meeting date, voting methods, agenda items, and proxy forms. It does not contain the actual annual report or financial statements but rather informs shareholders about the meeting and the items to be voted on, such as the 2016 annual report, financial budget, profit distribution plan, and audit report. The document length is 3202 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document is best classified as AGM Information (AGM-R).
2017-03-03 Chinese
信息披露暂缓与豁免管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy and procedural document regarding the management of information disclosure delays and exemptions for a company, including definitions, conditions, responsibilities, and approval processes. It references regulatory frameworks such as the Shanghai Stock Exchange listing rules and securities law, but it is not a financial report, earnings release, or any form of shareholder meeting material. It is a governance-related document outlining internal controls and compliance procedures for information disclosure. Therefore, it fits best under Governance Information (CGR). The document length is 2755 characters, which is relatively short but contains substantive policy content rather than a mere announcement or certification, so it is not RPA or RNS.
2017-03-03 Chinese
关于续聘会计师事务所的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of an accounting firm for auditing services for the fiscal year 2017. It mentions the completion of the 2016 audit and the decision to continue with the same auditor. The document is short (505 characters) and serves as a formal announcement rather than containing the audit report itself or detailed financial data. It fits the category of Audit Report / Information announcements, which include standalone audit reports or related information about audit engagements, but since it is an announcement about the auditor's reappointment and audit fees, it aligns best with Audit Report / Information (AR). FY 2016
2017-03-03 Chinese
2017-2019年股东回报规划
Regulatory Filings Classification · 95% confidence The document is a detailed policy outlining the company's shareholder return plan for the years 2017-2019, including principles, conditions, and procedures for profit distribution and dividend payments. It references regulatory guidelines from the China Securities Regulatory Commission and the Shanghai Stock Exchange, and it is issued by the company's board. The document is 3300 characters long, which is relatively short and does not contain actual financial statements or data. It is a policy or planning document rather than a financial report or announcement of voting results. It does not fit into categories like Annual Report, Earnings Release, or Dividend Notice. It is also not a report publication announcement since it contains substantive policy content rather than just announcing a report. The document is best classified as a Regulatory Filing (RNS) because it is a regulatory compliance document detailing the company's profit distribution policy and shareholder return plan, which does not fit other specific categories.
2017-03-03 Chinese
董事会审计委员会2016年度履职报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2016年度履职报告" (2016 Annual Performance Report) of the Board Audit Committee of 哈药集团股份有限公司. It details the activities, meetings, and evaluations conducted by the audit committee during the 2016 fiscal year, including oversight of external auditors, internal audit guidance, review of financial reports, and internal control assessments. The content is focused on the audit committee's work and their report to the board, rather than the full annual financial report or audit report itself. The document length is 2514 characters, which is relatively short and consistent with a committee report rather than a full audit report or annual report. This type of document fits best under the category of Audit Report / Information (AR), as it is a standalone audit committee report detailing audit-related activities and evaluations, but not the full annual report or financial statements themselves.
2017-03-03 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.